Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention

Circulation

Volumn 104, Issue 19, 2001, Pages 2289-2294

  Ruygrok, Peter N ^a,b   Webster, Mark W I ^a   De Valk, Vincent ^a   Van Es, Gerrit Anne ^a   Ormiston, John A ^a   Morel, Marie Angèle M ^a   Serruys, Patrick W ^a  

^a CARDIALYSIS   (Netherlands)

^b GREEN LANE HOSPITAL   (New Zealand)

Author keywords

Angioplasty; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COUMARIN ANTICOAGULANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; FLUINDOSTATIN; HEPARIN; NITRATE; WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE SEVERITY; FEMALE; HUMAN; HYPERLIPIDEMIA; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SEX DIFFERENCE;

EID: 0035818614     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4401.098294     Document Type: Article

References (34)

1. Predictive factors of restenosis after coronary stent placement
2. Predictors of diffuse-type in-stent restenosis after coronary stent implantation
3. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis at six months
4. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography
5. Effectiveness, costs and cost-effectiveness of a strategy of elective stenting compared to a strategy of balloon angioplasty allowing bail-out stenting in patients with coronary artery disease
6. Multicenter evaluation of the phosphorylcholine coated Biodivysio stent in short de novo coronary lesions: The SOPHOS study
7. Does six month follow-up angiography influence clinical management and outcome?
8. A comparison of balloonexpandable stent implantation with balloon angioplasty in patients with coronary artery disease
9. Heparin-coated Palmaz-Schatz stents in human coronary arteries: Early outcome of the Benestent II Pilot Study
10. Clinical and angiographic results with the ACS Multi-Link DUET coronary Stent system: The DUET study
11. Clinical and angiographic results with the NIR stent: First international NIR endovascular stent study
12. A randomized placebocontrolled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: Final results of the Fluvastatin Angiographic Restenosis (FLARE) Trial
13. Intravascular ultrasound-guided optimized stent deployment: Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)
14. Clinical and angiographic results with the beStent: The Registry for Optimal beStent Evaluation (ROSE) trial
15. Clinical and angiographic results with the Multi-Link coronary stent system: The West European Stent Trial (WEST)
16. Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II)
17. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty
18. Coronary angioplasty: Clinical and angiographic follow-up
19. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the National Heart, Lung, and Blood Institute
20. Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty
21. Which angiographic variable best describes functional status 6 months after successful singlevessel coronary balloon angioplasty?
22. Diagnostic of value of exercise electrocardiography and angina after coronary artery stenting
23. Differences in the use of procedures between women and men hospitalized for coronary artery disease
24. Sex differences in the management of coronary artery disease
25. Sex bias in considering coronary bypass surgery
26. Percutaneous transluminal coronary angioplasty in women compared with men
27. Sex, clinical presentation, and outcome in patients with acute coronary syndromes
28. Late regression of the dilated site after coronary angioplasty: A 5-year quantitative angiographic study
29. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: Serial angiographic and angioscopic follow-up
30. Impact of routine angiographic follow-up after angioplasty
31. Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus, J Am Coll Cardiol
32. Silent myocardial ischaemia: Role of subclinical neuropathy in patients with and without diabetes
33. Effect of diabetes mellitus on formation of coronary collateral vessels